# A Phase I Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetic Characteristics of TT-01025-CL in Healthy Subjects

> **NCT04730050** · PHASE1 · UNKNOWN · sponsor: **LG Chem** · enrollment: 64 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** TT-01025-CL

## Key facts

- **NCT ID:** NCT04730050
- **Lead sponsor:** LG Chem
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-02-17
- **Primary completion:** 2021-12
- **Final completion:** 2021-12
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2021-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04730050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04730050, "A Phase I Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetic Characteristics of TT-01025-CL in Healthy Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04730050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*